pros and cons of glp-1 medications Safety Check The Pros, Cons, and Considerations

Animal studies have also shown reduced tumor growth and metastasis in various cancer models

The FDA also recommends examining hard clinical endpoints such hepatic decompensations, transplant free survival, and all-cause mortality, although these results are not necessarily needed prior to drug approval given the long length of follow up potentially required

It may be related to toxicity, oxidative damage, poor nutritional status or nutritional deficiencies, heavy metal or environmental toxicity, systemic disorders, hormonal imbalances, xenobiotic exposure, age-related decline, or obesity

doi: 10.1002/ctm2.1300 144 ZhangBBaoWZhangSChenBZhouXZhaoJet al